Nasdaq (NASDAQ) · Technology
Flex Ltd. FLEX
SpeculativeScore band: 40–50
The thesis, in one sentence
Flex has genuinely reinvented itself, with rising margins and a spin-off announced, but at the current price the stock already reflects the bull case: several valuation methods land close to the price itself, leaving little margin of safety and a shrinking free-cash-flow yield.
Written for this site in plain English, without figures. The arithmetic is in the full report.
Key risks
- The stock already prices in the bull case for the turnaround
- Free cash flow yield is set to shrink toward guidance
- A planned spin-off adds execution and structural uncertainty
What would change the verdict
- Free cash flow yield rises to a level that restores a safety margin
- Operating margin climbs further for two consecutive quarters
- The price-to-earnings multiple falls to a cheaper level
- Revenue growth accelerates and holds for four consecutive quarters
Read it yourself
Step five of the method is the reader's: open the latest annual or quarterly report and read it before acting on anything here. A score is a summary, and a summary is not understanding.
Next report expected 2026-10-28. The deep report was written against the filings available on 2026-09-11; anything published since is not in it.
Price, one year
Open this week — scorecard, figures and executive summary
This ticker's exact score, its 30-criterion scorecard with the evidence behind each score, the DCF and Monte Carlo figures and the report's executive summary are open to everyone this week, no email required. The chapters after the summary are not — the demo ticker shows what a complete report looks like.
| Score | 40% (weighted sum out of 60 points) |
|---|---|
| DCF (min / base / max) | -81% / -61.6% / 4% |
| P(undervalued) | 0.8% (20,000 simulations) |
| p5 | p10 | p25 | p50 | p75 | p90 | p95 |
|---|---|---|---|---|---|---|
| -78.5% | -75.3% | -69.1% | -60% | -48.5% | -34.9% | -25.2% |
Percentiles, as a percentage margin against the reference price.
scenarios below today's pricescenarios above today's pricetoday's pricerange of the DCF modelsbase case
Scorecard — all 30 criteria
| # | Criterion | Evidence | Score |
|---|---|---|---|
| Graham | |||
| 1 | Current earnings multiple, against its own sectorpriced in the cheapest tier of its own sector | P/E ttm 43,6x (41,7x on diluted EPS 2,59) - own 5-fiscal-year median is 12,5x | 0 |
| 2 | Price to book — or cash generation, for intangible-heavy sectorsbook multiple low by the standards of its sector; for technology, semiconductors, pharma and e-commerce a high free-cash-flow yield replaces it, because book value means little there | P/B 7,25x; alternatively FCF yield 2,09% TTM (2,6% on FY2026) - below the 3% threshold | 0 |
| 3 | Earnings multiple times book multiplethe combined earnings-and-book multiple below a Graham-style ceiling | P/E x P/B = 43,6 x 7,25 = 316 (Graham threshold 22,5) | 0 |
| 4 | Dividend actually paida dividend paid without interruption over the last five years | Flex pays no dividend at all | 0 |
| 5 | Dividend yielda dividend yield well above what the average listed company pays | Dividend yield 0% | 0 |
| 6 | Leveragedebt below equity, or a net cash position; for banks and insurers this is judged on regulatory capital instead | D/E 107,8% (yfinance, with leases) / 95,3% on pure financial debt; net debt 2,40 bn = 1,17x EBITDA, interest coverage 6,5x, revolver 2,75 bn undrawn | 0.5 |
| 7 | Return on invested capital against the cost of that capitalreturns on invested capital clearly above what the capital costs; not computable for financials, which is why their denominator differs | ROIC 16,2% FY2026 (NOPAT 1.053 / invested capital 6.506), 14,1% TTM, above WACC ~10% | 0.5 |
| 8 | Earnings growth over five yearsearnings per share higher than they were five years ago | Diluted EPS 1,94 (FY2022) -> 2,33 (FY2026) -> 2,59 TTM | 1 |
| 9 | Consistency of profitprofitable in every one of the last five years | Positive profit in every one of the last 5 years (FY2022-FY2026: 936/793/1.010/838/880 mil USD) | 1 |
| 10 | Price against the Graham Numberprice below the Graham Number computed from earnings and book value | Graham Number = sqrt(22,5 x 2,48 x 14,89) = 28,83 USD vs price 108,01 (disc -73,3%) | 0 |
| Buffett | |||
| 11 | A durable moata competitive advantage that is clear and defensible — brand, network, switching cost, licence or cost position | Split moat: ITS (38% revenue) no moat and price taker, RMS (34%) real but modest regulatory moat, CPI (28%) scarce-capacity moat, cyclical and unproven over a cycle | 0.5 |
| 12 | How long the moat lastsan advantage that should still be standing a decade from now | RMS holds up for 10+ years (FDA/IATF recertification), CPI depends on the hyperscalers' capex cycle - durability 5-10 years on a weighted average | 0.5 |
| 13 | Return on equity, sustaineda high return on equity held for years without leaning on debt, measured after one-off gains are normalised away | ROE 17-18,4% in the last 3 years, but with D/E >1 -> 0,5 per the grid | 0.5 |
| 14 | Margins against the sectornet or operating margins above the sector average, by a clear gap | Net margin 3,15%, gross margin 9,2% - in the band of EMS peers (Jabil, Celestica), not 5pp above the sector; margins are rising simultaneously in all 3 segments | 0.5 |
| 15 | Quality of managementa management team with a long track record of allocating capital well | Advaithi CEO since Feb. 2019; operating margin 2,5% -> 4,9%, 3,84 bn bought back at ~31 USD average; question mark: CEO+CFO leave for SpinCo after the separation | 1 |
| 16 | Skin in the gamemanagement owns a meaningful part of the company and is not selling | heldPercentInsiders 0,61% (~245 mil USD) vs 96,8% institutions; the accumulation comes from grants (SBC +50% y/y), not open-market purchases | 0.5 |
| 17 | Predictabilitya business simple enough that next year can be reasoned about | Simple model (contract manufacturing), but volatile results: 12% concentration on one customer, tariff and memory-price pass-through, CPI separation in progress | 0.5 |
| 18 | Retained earnings put to workevery unit of profit kept in the business creates more than a unit of value | 3,84 bn bought back over 4 years at ~31 USD average with the stock at 108; a complete stop in Q1 FY2027 with 1,1 bn authorized unused; ROIC 16,2% > WACC 10% | 1 |
| 19 | Pricing powerable to pass inflation on to customers without losing them | Tariff and memory pass-through only 'where contractual mechanisms allow' - inflates revenue and reduces margin; ITS is explicitly a price taker | 0.5 |
| 20 | Margin of safety against the valuation modelsprice meaningfully below where the triangulated models put intrinsic value; for banks the dividend discount model is used, never analyst consensus | Median MOS -62% (triangulation of 5 models: -81% ... +4%); Monte Carlo: 0,8% probability of undervaluation | 0 |
| Lynch | |||
| 21 | Growth against the multiple paid for itthe multiple paid is small relative to the growth rate bought | Forward PEG 0,94 but on an unreliable yfinance forwardEps of 7,11 USD (55% above its own adjusted guidance); peg_trailing 3,17; on structurally sustainable growth PEG = 2,6 | 0 |
| 22 | Rate of profit growthearnings per share compounding fast over the last three years, after one-off and cyclical gains are normalised away | 3-year EPS CAGR: 1,72 (FY2023) -> 2,33 (FY2026) = 10,7%/year; the Q1 increase is helped by a one-off 37 mil gain on the disposal of a site | 0.5 |
| 23 | Fits a Lynch categoryclearly a fast grower, a stalwart or an asset play — not an ambiguous cyclical or a risky turnaround | Mixed: cyclical EMS (ITS/RMS) plus a fast grower (CPI) tied to the hyperscalers' capex cycle | 0.5 |
| 24 | An unfashionable corner of the marketin a business or a sector nobody is excited about | Intense coverage: 10 analysts, consensus target 160,50 USD (+48,6%), 96,8% institutional ownership, AI narrative in full swing | 0 |
| 25 | A story that can be told simplythe investment case can be explained in a couple of minutes, without jargon | Explainable in two minutes up to a point: a contract assembler now also selling power/cooling equipment; three segments recast in Q4 FY2026 and an ongoing separation complicate the story | 0.5 |
| 26 | Insider ownershipfounders or insiders hold a large stake and have been buying, not selling | Insiders 0,61%, no significant identified open-market purchases | 0 |
| 27 | A solid balance sheetnet cash, or debt far below equity | Net debt 2,40 bn = 1,17x EBITDA, 2,84 bn cash, revolver 2,75 bn undrawn; but gross D/E 0,95-1,08x and 2.349 mil (45% of debt) maturing in a single fiscal year, FY2028 | 0.5 |
| 28 | Market sharetaking share from competitors rather than merely defending it | Gaining share in CPI (+35% y/y, the EPP acquisition), losing in ITS (12.636 -> 11.109 mil over two years, -12%) | 0.5 |
| 29 | Analyst coveragefollowed by few institutional analysts, if any | 10 analysts, 96,8% institutions, market cap 39,9 bn - heavy coverage | 0 |
| 30 | Dilution from share-based payshare-based compensation consumes only a marginal slice of revenue each year | SBC 142 mil FY2026 / 27.914 mil revenue = 0,51%; annualized Q1 FY2027 204 mil / ~32 bn = 0,64% - below 1% | 1 |
Subtotals
| Graham | 3 |
|---|---|
| Buffett | 5.5 |
| Lynch | 3.5 |
| Total (30) | 12 |
| Score | 40% / 60 |
Executive summary, with figures
Deep-value analysis — FLEX (Flex Ltd., NASDAQ)
Analysis date: 09/11/2026 · Reference price: $108.01 · Market cap: $39.90 bil
Fiscal year ending March 31 · Reporting and pricing currency: USD (no conversion risk)
Primary sources: FY2026 10-K (filed 05/20/2026), Q1 FY2027 10-Q (filed 07/31/2026), FY2022-FY2025 10-K,
data pack rapoarte/deep/the automated data pack, simulation rapoarte/deep/the Monte Carlo simulation.
Executive summary
Flex is no longer the company it was three years ago, and the market understood that before I did. In two years, the cost-plus assembler with a 3.2% operating margin (FY2024) has become a group with a 4.9% GAAP operating margin and a segment — Cloud and Power Infrastructure — growing 35% per quarter, carrying a 9.7% margin, and set to represent roughly a third of revenue in FY2027. Management announced on 05/05/2026 the separation of CPI into an independently listed company (SpinCo), with a Form 10 expected in September 2026 and completion in calendar Q1 2027. FY2027 guidance was raised after Q1 to $33.7-35.2 bil revenue (+23% at the midpoint, versus $27.9 bil in FY2026) and $4.42-4.74 adjusted EPS (+40%). The business is in its best shape in a decade.
The problem isn't the business, it's the price. At $108.01 the stock trades at 41.7x trailing-four-quarter GAAP net profit ($2.59/diluted share) and 23.6x guided FY2027 adjusted EPS. Five fiscal years ago, at 03/31/2022, the same company traded at 7.2x profit. Of the 711% price increase over the last five years ($13.32 → $108.01), earnings per share contributed +40% ($1.85 → $2.59); nearly all the rest is multiple re-rating. The median P/E across the five fiscal years is 12.5x; today we pay 41.7x.
Free-cash-flow yield is the sharp end of the argument. Trailing-four-quarter FCFE (through 06/26/2026) is
$833 mil — $1,562 mil CFO minus $736 mil capex plus $7 mil disposals — i.e. 2.09% of market cap. It
isn't an accidentally depressed figure: the company's own FY2027 guidance is FCF conversion of ~40% of
adjusted net profit (revised down from 60%, for separation costs), which on adjusted profit of $1,713 mil
gives **$685 mil FCF in FY2027**, i.e. a 1.72% yield — below today's. Capex rises from $633 mil (FY2026) to
a guided $1.5-1.6 bil (FY2027), 2.4x, and in Q1 FY2027 free cash flow was $41 mil versus $268 mil a year
earlier, an 85% drop in a quarter when revenue grew 21%.
I triangulated five models. The FCFE DCF with a normalized base ($900 mil, i.e. TTM FCFE plus one-off separation costs) and assumptions g1=9%, r=10.5%, gt=2.5% gives $42.87/share, with a margin of safety of −60.3%. The bear model, starting directly from FY2027-guided FCF ($685 mil), gives $25.18 (−76.7%). Earnings Power Value à la Greenwald, at the mid-cycle average operating margin of 4.4% and a 10% WACC, gives $20.35 (−81.2%). Historical multiples (median P/E 12.5x over five fiscal years, applied to an estimated FY2027 GAAP EPS of $3.32) give $41.50 (−61.6%). The only model that reaches the current price is the bull case, and only because I build it generously: base $1,650 mil (estimated FY2028 free cash flow of $2.0 bil, discounted back two years), g1=12% over ten years, r=9.5%, gt=3% — and it still only reaches $112.57, a +4.2% margin. In other words, today's price is the bull scenario, executed flawlessly.
The Monte Carlo simulation (20,000 scenarios, same central assumptions as Model 2) confirms this: median intrinsic value $43.15, median margin of safety −60.0%, probability the stock is undervalued 0.8%, probability of a margin above 30% 0.1%. The P10-P90 range of the margin is −75.3% … −34.9%: even the optimistic tail of the distribution stays deeply negative. For intrinsic value to reach the current price with a base of $900 mil and r=10.5%, sustained growth of 25.8% per year for five years and 12.9% for the following five would be needed — above the peak-year revenue growth guidance, sustained for a decade.
Verdict: AVOID at $108. This isn't a short thesis — earnings quality is decent, the balance sheet is solid (net debt $2.4 bil, 1.17x EBITDA), and capital allocation has historically been excellent. It's a price thesis: there is no margin of safety, and none appears except below ~$55-60 for a buyer requiring a 30% MOS, or below ~$70 for a buyer who accepts the bull thesis with its full assumptions. The level to watch is $70 — the price at 03/31/2026, before the rally that took the stock to $162 in June and from which it has already corrected 33%.
Why the analysis was rerun. The mechanical triage the quarter-over-quarter table flagged FULL because a falsifier on
fcf_yield tripped. The check is mandatory and the answer is unflattering for the procedure: the falsifier
in the 08/19/2026 thesis was set at a threshold of 0.0186 — exactly the value of the metric at the time it
was written. The price fell from $120.24 to $108.01 (−10.2%), the yield mechanically rose to 2.09% (TTM) or
2.64% (on the FY2026 basis used by the indicator script), and the threshold gave way. It didn't break
because the business generated more cash — on the contrary, quarterly FCF fell 85%. A threshold set at the
metric's current value falsifies nothing, it merely detects price movement. The correct threshold for this
thesis is 0.045, a level that would actually change the verdict if reached.
That is chapter one of the deep report, figures included. Chapters two onwards stay closed for the five open tickers. See what a complete analysis looks like — this week's demo ticker: SNT Energy Co., Ltd. (100840) →
Full report contents
- Executive summary
- 🔒 Business and moat (Available in the full report)
- 🔒 Management and capital allocation (Available in the full report)
- 🔒 What changed in the last 4 quarters (Available in the full report)
- 🔒 Balance sheet analysis — Quality of Earnings (Thornton O'Glove method) (Available in the full report)
- 🔒 CEO profile — Outsider traits (William Thorndike method) (Available in the full report)
- 🔒 Accounting red flags (Available in the full report)
- 🔒 Triangulated valuation (Available in the full report)
- 🔒 Pre-mortem (Available in the full report)
- 🔒 Verdict compared with the GBL tracker score (Available in the full report)
See what a complete analysis looks like — this week's demo ticker: SNT Energy Co., Ltd. (100840) →
Evaluation history
| Date | Verdict |
|---|---|
| 2026-08-19 | Speculative |
| 2026-08-25 | Avoid |
| 2026-09-06 | Avoid |
| 2026-09-11 | Speculative |
Want next week's reports too?
The scorecard, the valuation figures and the executive summary are open to everyone this week; the remaining chapters are not. Subscribers get one full deep report a week by email, the day before it opens here — and the weekly list of what cleared the filters.